BACKGROUND: Visceral obesity is more closely associated with many deleterious metabolic sequelae than obesity per se. The identi®cation of properties that distinguish fat cells of the omentum from adipocytes situated elsewhere in the body may lead to the development of therapeutic strategies targeting visceral obesity. We have previously demonstrated that cIAP2 mRNA is signi®cantly overexpressed in omental (Om) compared with subcutaneous (Sc) adipocytes. This molecule is involved in the TNFa signalling pathway and may inhibit apoptosis. OBJECTIVE: To examine the effect of serum agents and TNFa upon cIAP2 mRNA expression in human primary culture preadipocytes. DESIGN: Paired omental and subcutaneous adipose tissue biopsies were obtained from 11 patients, nine female and two male, with ages ranging from 29 to 82. These were cultured in either serum containing medium or serum-free medium with or without the addition of TNFa for 4 h and mRNA levels analysed by quantitative reverse-transcription polymerase chain reaction. RESULTS: When human preadipocytes were cultured in a de®ned medium containing foetal calf serum the Om cells had a greater level of expression of cIAP2 mRNA than Sc cells from the same individual (mean 3.5-fold higher Sc b Om; P`0.01). However, when serum was removed from this media for a transitory period the level of cIAP2 mRNA decreased in the omental depot such that Sc preadipocytes had greater cIAP2 expression than their Om counterparts. Addition of TNFa induced a large increase in mRNA levels of cIAP2 (mean 20-fold).
Introduction
It is now well established that fat storage in the visceral adipose depots is more deleterious to health than fat storage in subcutaneous adipose depots. Numerous epidemiological studies demonstrate that the metabolic syndromes closely associated with obesity, such as non-insulin-dependent diabetes mellitus (NIDDM), hyperlipidaemia, cardiovascular disease and syndrome X, are more tightly correlated with markers of central adiposity than the degree of overall adiposity. 1, 2 There are a number of potential reasons for the deleterious effects of central adiposity, including the anatomical site of fat storage and the pattern of its venous drainage. As the central, visceral adipose depots drain into the portal venous system, the non-esteri®ed fatty acids (NEFAs) are transported to the liver where they can be used as a substrate for hepatic glucose production and lipoprotein metabolism and thus may mediate disturbances in insulin sensitivity and plasma glucose concentrations. In contrast, the subcutaneous adipose depots drain into the systemic venous system and NEFAs are distributed around the body. However, there may also be intrinsic properties of visceral adipocytes that contribute to the increased pathophysiology observed with central obesity. In order to address this possibility, numerous studies have been performed to investigate differences in biochemistry and gene expression between cells from the omental and subcutaneous adipose depots.
Omental and subcutaneous adipocytes display differences in various basal metabolic properties regulating fat cell volume. In vivo, omental fat cells display a greater lipid¯ux than subcutaneous cells. 1, 3, 4 In vitro, triglycerides are more easily mobilised from visceral than subcutaneous adipose depots, and adipocytes isolated from the omental depot demonstrate a higher basal and catecholamine-induced activation of adenylate cyclase, the membrane-bound enzyme mediating lipolytic stimuli, than subcutaneous adipose tissue. 5, 6 Glucocorticoid receptor density and mRNA levels, and also lipoprotein lipase activity, have been shown to be higher in adipocytes from the visceral as compared to subcutaneous adipose depots. 6 ± 8 Regional variations in the capacity of preadipocyte differentiation have been also been reported.
Subcutaneous preadipocytes differentiate more readily in response to thiazolidinediones than the omental cells from the same individual. 9 Finally, human preadipocytes and adipocytes from the omental depot display greater rates of apoptosis than cells from the subcutaneous adipose depots of the same individuals. 10, 11 An understanding of the underlying mechanisms for the depot-speci®c differences mentioned has been aided by the identi®cation of numerous site-related differences in the expression of genes involved in adipose cell metabolism. Omental and subcutaneous adipocytes display signi®cant differences in the level of mRNA expression of genes involved in adipose cell metabolism. Levels of GLUT4, glycogen synthase, insulin receptor, leptin and PPARg mRNA expression are all signi®cantly higher in subcutaneous than omental adipose tissue. 12, 13 A recent study which used differential display RTPCR to compare mRNA expression patterns of subcutaneous and omental adipocytes demonstrated that the cellular inhibitor of apoptosis protein-2 (cIAP2) is expressed at higher levels in omental than subcutaneous adipocytes. 14 The inhibitor of apoptosis (IAPs) gene products comprise a family of proteins which are highly conserved throughout several species and play a role in the regulation of apoptosis in viruses, insects, nematodes and mammals. 15 ± 17 IAPs were originally identi®ed in baculoviruses as proteins which could facilitate the survival and propagation of the virus by suppressing the cell death response in the host. 15,18 ± 22 Five human homologues have subsequently been identi®ed (NAIP, XIAP, cIAP1, cIAP2, survivin) and overexpression studies have shown that these proteins can protect against apoptosis induced by a variety of stimuli. 23 ± 25 A recent report has shown that the differentiation-dependent expression of the neuronal apoptosis inhibitory protein (NAIP) in adipose cell lines may correlate with the development of resistance of adipocytes to apoptosis. 26 We have previously reported that human preadipocytes from the omental depot are more susceptible to apoptosis induced by TNFa and serum deprivation, and that cIAP2 is expressed in human adipocytes in a site-speci®c manner. 10, 14 The aim of the current study was therefore to determine whether cIAP2 is expressed differentially in human preadipocytes in a manner which could support the observed adipose depot-speci®c susceptibility to apoptosis.
Methods
Patients and sample acquisition Patients undergoing elective surgery at Addenbrooke's Hospital (Cambridge, UK) were recruited for the study. The experimental protocols were approved by the Institution's Ethics Committee and all patients gave their informed consent to the procedure. Patient details are outlined in Table 1 . No patients were on medications known to affect adipose tissue mass, distribution or metabolism and none had severe systemic illness or known malignancy. All patients fasted for at least 8 h prior to surgery and all underwent general anaesthesia. Subcutaneous and omental adipose tissue biopsies were obtained at the time of surgery and immediately Adipose depot-speci®c expression of cIAP2 CU Niesler et al transported to the laboratory in sterile normal saline (transport time 5 ± 10 min).
Preadipocyte isolation and culture
Human preadipocytes were isolated as originally described by Rodbell 27 with modi®cations. 28, 29 When 80 ± 90% conuent, the cells were trypsinised and subcultured in SCM into T75 cm 2¯a sks (two¯asks per treatment) for RNA extraction. SCM comprised DMEMaHam's F12 with 10% foetal bovine serum, 100 Uaml penicillin, 0.1 mgaml streptomycin and 2 mM glutamine. All preadipocytes were used between passages three and ®ve. To induce apoptosis, cells were washed twice in PBS and incubated in serum-free medium (SFM) with or without recombinant human TNFa (25 nM) for 4 h. These conditions had been determined in our previous study. 30 Paired biopsies were obtained from 11 patients, nine female and two male, with ages ranging from 29 to 82 (see Table 1 ). Cells from 11 patients were cultured in either SCM (patients 1 ± 8), SFM (patients 6, 9 and 10) or SFM TNFa (patients 8 ± 11) for 4 h. Total RNA was extracted using TriReagent (Sigma) according to the manufacturer's protocol and QRTPCR carried out as described below.
Quantitative RTPCR The cIAP2 internal standard RNA was constructed for a previous study and the details of its manufacture are described there Quantitative reverse transcription polymerase chain reaction (RTPCR) was performed as described previously.
14 Brie¯y, the internal standard RNA was ampli®ed by the same RTPCR primers and in the same tube as the preadipocyte RNA. Multiple reverse transcription reactions were performed for each preadipocyte RNA, the reactions differing only in the concentration of internal standard RNA. A reaction from which the reverse transcriptase and internal standard RNA was omitted acted as a control for any residual DNA in the subject RNA sample. PCR ampli®cation of the ®rst strand cDNA using cIAP2 speci®c primers (sense, 5
H TTGCTGTGGTGGAAAATTG3 H ; anti-sense, 5 H GCAAGCT-GCTCAGGATTAAC3 H ) was performed in a 100 ml reaction volume using standard concentrations of reagents. Cycling parameters were: 94 C for 1 min; 55 C for 45 s; 72 C for 1 min (40 cycles); 72 C for 5 min (one cycle). The RTPCR ampli®ed products were digested using EcoRI restriction enzyme, separated on a 2% agarose gel and stained with EtBr. The internal standard generated a digested PCR product of 191 bp in length while the wild-type mRNA generated a digested product of 214 bp in length. The density of the wildtype and internal standard bands were measured using NIH Image Software (NIH, USA). To determine the point of equivalence (at which the densities of the wild-type and internal standard bands were equal) the log of the ratio of the internal standard to the wild-type band densities was plotted against the log of the internal standard concentration. The resultant curve was rectilinear with a slope of 1, demonstrating that the internal standard was ampli®ed with the same ef®ciency as the wild-type mRNA. The equivalence points for adipocyte RNA were used to calculate the copynumber of wild type cIAP2 RNA per pg total preadipocyte RNA.
Statistical analysis
Statistical analysis was carried out using the paired Student's t-test.
Results
Expression of cIAP2 in omental and subcutaneous preadipocytes cultured in serum containing medium To compare the cIAP2 mRNA expression levels of cells in the basal condition, the preadipocytes from eight patients were cultured for 4 h in SCM. RNA was isolated and the cIAP2 expression levels analysed by QRTPCR. In seven out of eight samples, the expression level was greater in the preadipocytes of the omental depot when compared with the subcutaneous depot (paired t-test: P`0.01, Figure 1a ). The mean cIAP2 expression was 3.5-fold higher in the omental depot than the subcutaneous depot (Figure 1b ; omental 3800 AE 1100; subcutaneous 1100 AE 240).
Expression of cIAP2 in omental and subcutaneous preadipocytes cultured in serum-free medium
To determine whether removal of serum alters the cIAP2 ratio between the two depots, paired human preadipocytes from three patients were cultured in serum free medium for 4 h and the mRNA expression level determined by QRTPCR. Removal of serum alters cIAP2 expression in the two depots such that mRNA levels in the subcutaneous depot were greater than those in the omental depot for all three patients (Figure 2a) . Due to the small sample number the Student's t-test, although indicating P`0.05, is not applicable for this set of data. When the mean cIAP2 mRNA copy numbers were compared with those seen in preadipocytes cultured in SCM, the mean expression levels of cIAP2 in preadipocytes cultured in SFM was decreased in the omental depot, whereas those in the subcutaneous depot remained fairly constant (omental, 570 AE 200; subcutaneous, 1200 AE 460; compare Figures 1b and 2b) . Such a rapid change in expression may imply a short half-life of the mRNA.
Expression of cIAP2 in omental and subcutaneous preadipocytes cultured in TNFa in the absence of serum To determine whether the addition of TNFa in serum free medium brought about any change in cIAP2 expression level from that seen with SFM alone, cells were incubated with SFM TNFa (25 nM) for 4 h and cIAP2 expression analysed as before. In all four subjects the expression levels of cIAP2 were greater in the subcutaneous than the omental depot ures 2b and 3b) . Hence, the depot-speci®c difference seen with SFM alone was maintained under these conditions, albeit with higher expression levels of cIAP2.
Discussion
The human cIAP1 and cIAP2 were originally identi®ed as proteins which associate with TNFa -associated factor (TRAF) proteins, TRAF-1 and TRAF-2, and are recruited to the cytosolic domain of the 75 kDa tumor necrosis factor receptor 2 (TNFR2). 16, 21, 32 The precise function of these proteins in the TNFa signalling cascade is still unclear. 16 Recent studies have
shown that both cIAP1 and cIAP2 are direct inhibitors of caspase-3, -7, and -9 but not caspase-8, -1 or -6. 15, 16 Caspases-3, -6 and -7 are terminal effector cell death proteases which can be activated by both the proximal protease caspases-8 or -9. 15, 16 These proximal caspases therefore represent two distinct mechanisms whereby the activation of common executioner caspases can be achieved. It would seem that, by in¯uencing caspase-9, the cIAPs may be able to regulate one arm of the apoptosis pathway.
Members of the IAP family of anti-apoptotic proteins have been implicated in the prevention of apoptosis in response to numerous death signals. 22, 23, 33, 34 To date, several studies have shown that, when overexpressed in mammalian cells, cIAP2 protects against apoptosis induced by TNFa, serum deprivation and overexpression of caspase-1, -2 and -3. 23, 24, 34 However, other studies have failed to show an inhibition of Adipose depot-speci®c expression of cIAP2 CU Niesler et al apoptosis by cIAP2. 21, 23 We have previously shown that human preadipocytes display a depot-speci®c susceptibility to apoptosis. To explore the molecular mechanisms resulting in the observed depot-speci®c apoptotic susceptibility, we chose to investigate cIAP2 expression levels in these cells. cIAP2 had already been shown to be differentially expressed in human adipocytes from different adipose depots. 14 When the cIAP2 mRNA expression levels in omental and subcutaneous human preadipocytes were examined by QRTPCR, cIAP2 was found to be differentially expressed. The ratio and level of expression was dependent upon the culture conditions. When preadipocytes were cultured in serum-containing medium cIAP2 mRNA expression was greater in the cells from the omental depot than those from the subcutaneous depot (Figure 1) . However, the removal of serum resulted in an inversion of this ratio such that subcutaneous preadipocytes contained greater cIAP2 mRNA levels than their omental counterparts (Figure 2 ). This was due to a decrease in expression in the omental depot, whereas expression in the subcutaneous depot remained constant. Addition of TNFa to the cells in the absence of serum did not change the ratio of expression, but did result in a large increase in cIAP2 expression levels in both omental and subcutaneous depots (Figures 2 and 3) .
The results presented here are consistent with the depotspeci®c difference in apoptosis observed in human preadipocytes. 10 Omental human preadipocytes cultured in serum-free medium with or without the addition of TNFa display greater apoptotic indices than their subcutaneous counterparts and, consistently, the cIAP2 expression levels are lower in the omental than the subcutaneous depot. However, it is puzzling that, under conditions where apoptosis is greatest (addition of TNFa), the expression of cIAP2 is highest. This may suggest that, in a self-regulatory manner, TNFa induces cIAP2 expression in order to invoke a ceiling on the extent of apoptosis. When human preadipocytes are cultured in serum-containing medium the basal apoptotic index is very low making it impossible to correlate the differential preadipocyte cIAP2 expression to apoptosis under these conditions. The current results do not directly link cIAP2 to the protection from apoptosis in response to either serum deprivation or TNFa. To show such a cause ± effect relationship one would have to modulate the cIAP2 levels within the cell and monitor the apoptotic response in parallel. Indeed, this has been carried out in other cell types and it has been demonstrated that inhibition of cIAP2 upregulation does result in an increase in apoptosis in response to TNFa. 33, 34 The increase in preadipocyte cIAP2 mRNA expression level upon addition of TNFa is consistent with that reported to occur in other cell types. 33, 34 However, this is the ®rst time that this mechanism has been demonstrated in preadipocytes and indicates the importance of TNFa signalling in adipose cells. Addition of TNFa to cells is known to activate the apoptotic caspases (particularly caspase-8) as well as the survival NFkB pathway. 22, 34 cIAP1 and cIAP2 were originally puri®ed as part of the TNFa receptor signalling complex, suggesting that they may be involved in the regulation of apoptosis in response to TNFa . Furthermore, an increase in cIAP2 expression in response to TNFa has been shown to be mediated by NFkB and conversely, when overexpressed in mammalian cells, cIAP2 activates NFkB. This suggests a positive feedback mechanism of activation of NFkB and further implicates cIAP2 as an anti-apoptotic modulator of the TNFa death-inducing signal. 33, 34 According to these observations, the sensitivity of the cell to TNFa could rely on the balance between caspase activation and NFkB induction. 22 Upregulation of cIAP2 in all cells in response to TNFa may be a way in which the healthy cells may modulate the effectiveness of the apoptotic insult. Adipose depot-speci®c expression of cIAP2 CU Niesler et al Cells with higher expression levels of cIAP2 have been shown to be less susceptible to apoptosis induced by various insults than cells with lower cIAP2 expression levels. 33 One could therefore speculate that human preadipocytes show a very low sensitivity to TNFa-induced apoptosis due to the dramatic increase in cIAP2 expression in response to TNFa. Furthermore, the rapid change in cIAP2 expression levels in response to the removal of serum or addition of TNFa indicates that a site-speci®c regulation of cIAP2 expression may be under endocrineaparacrine control. cIAP2 mRNA copy numbers have been documented in isolated human adipocytes.
14 When compared with human preadipocytes cultured in SCM, human isolated adipocytes have lower cIAP2 mRNA levels and are also more susceptible to TNF-induced apoptosis. 10, 14, 30 As cIAP2 is under endocrineaparacrine control, changes in serum composition during weight-loss or weight-gain may alter the cIAP2 ratios between omental and subcutaneous depots. This could impact on the apoptotic susceptibility of the cells in a depot-speci®c manner and bring about a deleterious change in regional fat deposition or loss.
In conclusion, cIAP2 is expressed in human preadipocytes in a depot-speci®c manner. The expression of this factor is strongly regulated by serum factors and TNFa. This suggests that the differential expression of cIAP2 is due to inherent properties of the cells from distinct depots as well as the action of endocrineaparacrine factors.
